2020 News
-
Information
Santen to Present Latest Data on MicroShunt at 14th EGS Congress
-
Information
-
Information
Santen to Present Latest Data on Omidenepag Isopropyl and Microshunt at AAO 2020 Virtual
-
Press Release IR News
Santen Reports the 2nd Quarter Fiscal 2020 Consolidated Performance
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
-
Information
-
Press Release IR News
-
Press Release IR News
-
Information
-
Information
-
Information
Announcing Addition of Third Building to Shiga Product Supply Center's Site
-
Press Release IR News
Santen and U.S. Ophthalmic Company Eyevance Enters into Share Purchase Agreement
-
Press Release IR News
-
Information
-
Press Release
-
Press Release
-
Information
Corporate Social Responsibility (CSR) page on our website has been updated
-
Press Release IR News
Santen Reports the 1st Quarter Fiscal 2020 Consolidated Performance
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
Notice on the Disposal of Treasury Shares Under Restricted Stock-Linked Remuneration Program
-
Information
-
Press Release IR News
-
Information
-
Press Release IR News
Providing Eye Care Information to Resolve Problems Caused by Excessive Screen Time
-
Press Release IR News
-
Information
Santen's Measures to Combat Novel Coronavirus Infections (COVID-19) (No. 3)
-
Press Release IR News
Notice of Board of Director and Corporate Auditor Nominations
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
Santen Introduces Eco-Friendly Biomass Plastic Eyedrop Bottles
-
Information
Santen Pharmaceutical measures to combat the disease caused by the novel coronavirus (COVID-19)
-
Press Release IR News
-
Information
Santen's Measures to Combat Novel Coronavirus Infections (COVID-19) (No. 2)
-
Press Release IR News
-
Press Release IR News
Santen and TRACON Discontinue Development of DE-122 for Wet Age-Related Macular Degeneration
-
Press Release IR News
-
Information
Santen's Measures to Combat Novel Coronavirus Infections (COVID-19) (No. 1)
-
Information
-
Press Release IR News
-
Press Release IR News
Santen and Verily Establish Joint Venture to Develop and Commercialize Unique Ophthalmic Devices
-
Press Release IR News
Santen Reports the 3rd Quarter Fiscal 2019 Consolidated Performance
-
Press Release IR News
Santen Pharmaceutical Selected as Title Sponsor of IBSA Blind Football World Grand Prix 2020!
-
Press Release IR News
-
Press Release IR News